Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans

[1]  J. Levine,et al.  Sensory and sympathetic contributions to nerve injury-induced sensory abnormalities in the rat , 1995, Neuroscience.

[2]  Pierre N. M. Konings,et al.  Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro , 1994, Brain Research.

[3]  M. E. Lewis,et al.  Insulin-like Growth Factor-I: Potential for Treatment of Motor Neuronal Disorders , 1993, Experimental Neurology.

[4]  G. Lewin,et al.  Nerve growth factor-induced hyperalgesia in the neonatal and adult rat , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  W D Willis,et al.  Cutaneous sensory receptors in the rat foot. , 1993, Journal of neurophysiology.

[6]  R. Meyer,et al.  Chemosensitivity and sensitization of nociceptive afferents that innervate the hairy skin of monkey. , 1993, Journal of neurophysiology.

[7]  M. Ashburn,et al.  Management of Pain in the Cancer Patient , 1993, Anesthesia and analgesia.

[8]  G. Gebhart,et al.  Neonatal capsaicin treatment prevents the development of the thermal hyperalgesia produced in a model of neuropathic pain in the rat , 1992, Pain.

[9]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[10]  K. Davis,et al.  The plasticity of cutaneous hyperalgesia during sympathetic ganglion blockade in patients with neuropathic pain. , 1992, Brain : a journal of neurology.

[11]  P. Reeh,et al.  Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  Z. Seltzer,et al.  Effects of sympathectomy in a model of causalgiform pain produced by partial sciatic nerve injury in rats , 1991, PAIN.

[13]  A. Forman.  Peripheral neuropathy in cancer patients: clinical types, etiology, and presentation. Part 2. , 1990, Oncology.

[14]  J. Levine,et al.  Involvement of the mu-opiate receptor in peripheral analgesia , 1989, Neuroscience.

[15]  V. Vuorinen,et al.  The long-term effects of a single injection of taxol upon peripheral nerve axons , 1989, Journal of neurocytology.

[16]  J. Levine,et al.  The contribution of training to sensitivity in the nociceptive paw-withdrawal test , 1989, Brain Research.

[17]  J. Beijnen,et al.  Degradation kinetics of vincristine sulphate and vindesine sulphate in aqueous solutions , 1989 .

[18]  J. Beijnen,et al.  Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[19]  D. Price,et al.  Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block , 1989, Pain.

[20]  T. Shippenberg,et al.  Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. , 1989, The Journal of pharmacology and experimental therapeutics.

[21]  Golden Dl,et al.  Uses of vincristine and vinblastine in dogs and cats. , 1988 .

[22]  J. Atkins,et al.  Amelioration of vincristine neurotoxicity by glutamic acid. , 1988, The American journal of medicine.

[23]  M. Fiori,et al.  Ganglioside treatment of vincristine-induced neuropathy. An electrophysiologic study. , 1988, Toxicology.

[24]  R. Meyer,et al.  Myelinated afferents signal the hyperalgesia associated with nerve injury , 1988, Pain.

[25]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[26]  G. Powis,et al.  Effect of some anticancer drugs on the surface membrane electrical properties of differentiated murine neuroblastoma cells. , 1987, Journal of the National Cancer Institute.

[27]  R. Henderson,et al.  Peripheral Neuropathy Associated with Malignant Neoplasms in Dogs , 1987, Veterinary pathology.

[28]  A. Harding,et al.  A study of the effects of isaxonine on vincristine-induced peripheral neuropathy in man and regeneration following peripheral nerve crush in the rat. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[29]  B. Csillik,et al.  Iontophoretically applied microtubule inhibitors induce transganglionic degenerative atrophy of primary central nociceptive terminals and abolish chronic autochtonous pain , 1982, Acta neurologica Scandinavica.

[30]  R. LaMotte,et al.  Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  R. Kaplan,et al.  Neurotoxicity of antineoplastic drugs. , 1982, Seminars in oncology.

[32]  R T Verrillo,et al.  Sensory functions in chronic neuralgia. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[33]  F. Samson,et al.  Axonal transport disturbances in vincristine‐induced peripheral neuropathy , 1977, Annals of neurology.

[34]  D Grob,et al.  Vincristine treatment of advanced cancer: a cooperative study of 392 cases. , 1973, Cancer research.

[35]  P. M. L. Quesne,et al.  Vincristine neuropathy. Clinical and electrophysiological observations. , 1973, Brain : a journal of neurology.

[36]  E. Henderson,et al.  Vincristine‐induced neuropathy , 1969, Neurology.

[37]  H. Barry,et al.  Influence of certain parameters on the performance of mice on the rotarod. , 1967, Archives internationales de pharmacodynamie et de therapie.

[38]  S. Taylor,et al.  EXPERIENCE WITH VINCRISTINE IN SOLID TUMORS. , 1963, Cancer chemotherapy reports.

[39]  N W DUNHAM,et al.  A note on a simple apparatus for detecting neurological deficit in rats and mice. , 1957, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[40]  G. Sobue,et al.  Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion explants in vitro. , 1994, Life sciences.

[41]  A. Forman.  Peripheral neuropathy in cancer patients: incidence, features, and pathophysiology. , 1990, Oncology.

[42]  G. Wallin,et al.  PRELIMINARY OBSERVATIONS ON THE PATHOPHYSIOLOGY OF HYPERALGESIA IN THE CAUSALGIC PAIN SYNDROME , 1976 .